SELLAS Life Sciences (SLS) Revenue Growth (1y) (2013 - 2022)
SELLAS Life Sciences (SLS) Revenue Growth (1y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 96.43% |
| 10 | SELLAS Life Sciences | 1.84 Bn | 1.74 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -82.46% |
| Jun 30, 2015 | 45.09% |
| Mar 31, 2015 | 26.55% |
| Dec 31, 2014 | 0.00% |
| Sep 30, 2014 | 0.00% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | 0.00% |
| Dec 31, 2013 | 373.08% |
| Sep 30, 2013 | 38.46% |